An Empirical Approach Leveraging Tumorgrafts to Dissect the Tumor Microenvironment in Renal Cell Carcinoma Identifies Missing Link to Prognostic Inflammatory Factors. Read more about An Empirical Approach Leveraging Tumorgrafts to Dissect the Tumor Microenvironment in Renal Cell Carcinoma Identifies Missing Link to Prognostic Inflammatory Factors.
E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast Cancer. Read more about E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast Cancer.
Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAFV600E-Mutant Colorectal Cancer. Read more about Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAFV600E-Mutant Colorectal Cancer.
Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer. Read more about Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer.
Tissue Force Programs Cell Fate and Tumor Aggression. Read more about Tissue Force Programs Cell Fate and Tumor Aggression.
Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma. Read more about Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma.
BLIMP1 Induces Transient Metastatic Heterogeneity in Pancreatic Cancer. Read more about BLIMP1 Induces Transient Metastatic Heterogeneity in Pancreatic Cancer.
Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations. Read more about Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations.
Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of BRCA2 Reversion Mutations Associated with Resistance to PARP Inhibitors. Read more about Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of BRCA2 Reversion Mutations Associated with Resistance to PARP Inhibitors.
BCL6 Antagonizes NOTCH2 to Maintain Survival of Human Follicular Lymphoma Cells. Read more about BCL6 Antagonizes NOTCH2 to Maintain Survival of Human Follicular Lymphoma Cells.
